Download PDF
Planta Med 2014; 80(08/09): 637-644
DOI: 10.1055/s-0034-1368584
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Neuroprotective Effects of Total Steroid Saponins on Cerebral Ischemia Injuries in an Animal Model of Focal Ischemia/Reperfusion

Xinxin Zhang
1   Biomedicine Key Laboratory of Shaanxi Province, Northwest University, Xiʼan, China
,
Lin Chen
1   Biomedicine Key Laboratory of Shaanxi Province, Northwest University, Xiʼan, China
,
Xuan Dang
1   Biomedicine Key Laboratory of Shaanxi Province, Northwest University, Xiʼan, China
,
Jianli Liu
1   Biomedicine Key Laboratory of Shaanxi Province, Northwest University, Xiʼan, China
,
Yoichiro Ito
2   Laboratory of Bioseparation Technology, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
,
Wenji Sun
1   Biomedicine Key Laboratory of Shaanxi Province, Northwest University, Xiʼan, China
› Author Affiliations
Further Information

Publication History

received 22 February 2014
revised 25 April 2014

accepted 12 May 2014

Publication Date:
25 June 2014 (online)

    Permissions and Reprints

Abstract

Total steroid saponins isolated from Dioscorea zingiberensis are a unique traditional Chinese medicine known for its potential usage in various types of diseases. However, there is little evidence about its neuroprotective effect in transient focal ischemia-reperfusion cerebral injury. Therefore, the current study was carried out to investigate the effect of total steroid saponins on neuroprotection and its potential mechanisms in the rat ischemia-reperfusion model by middle cerebral artery occlusion for 90 min. The rats were each treated with total steroid saponins (30 mg/kg, 10 mg/kg, and 3 mg/kg) or nimodipine (20 mg/kg) daily for 6 days before middle cerebral artery occlusion. Then, the neurological deficit score, cerebral infarct volume, and brain water content were measured at 24 h after reperfusion. Meanwhile, the histopathological changes and AQP-4 protein activities were examined in hippocampal CA1 and the cortex of ipsilateral ischemic cerebral hemisphere by hematoxylin-eosin staining and immunohistochemistry, respectively. The indices of oxidative stress in the serum were also obtained, and NF-κB and ERK 1/2 protein expressions in the injured brain were evaluated by Western blotting. The results indicated that the pre-treatment with these drugs not only significantly reduced cerebral infarct volume, brain water content and improved neurological deficit score, but also restored neuronal morphology and decreased the AQP-4 positive cells in CA1 and the cortex. Moreover, it markedly restored the level of oxidant stress markers (CAT, SOD, MDA, NO and iNOS) to their normal range in serum. In addition, the increased NF-κB and ERK 1/2 protein expressions were alleviated as compared with the ischemia-reperfusion group. These findings demonstrate that total steroid saponins exhibit promising neuroprotection effects against the transient focal ischemia-reperfusion cerebral injury in the rat experimental model and the underlying mechanisms might be mediated through inhibition of anti-edema as well as anti-oxidative effects by inactivation of NF-κB and ERK 1/2 signalling pathway.

Key words

Dioscorea zingiberensis - Dioscoreaceae - steroid saponins - middle cerebral artery occlusion - ischemia-reperfusion - anti-edema - anti-oxidative
 

  • References

  • 1 Xi QZ, Xiao NZ, Hui K, Xiu LS. Neuroprotective effects of berberine on stroke models in vitro and in vivo . Neurosci Lett 2008; 447: 31-36
    CrossrefPubMedGoogle Scholar
  • 2 Zhu YM, Wang CC, Chen L, Qian LB, Ma LL, Yu J, Zhu MH, Wen CY, Yu LN, Yan M. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res 2013; 1494: 1-8
    CrossrefPubMedGoogle Scholar
  • 3 Dirnagl U, Ladecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-397
    CrossrefPubMedGoogle Scholar
  • 4 Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003; 4: 399-415
    PubMedGoogle Scholar
  • 5 Li H, Deng CQ, Chen BY, Zhang SP, Liang Y, Luo XG. Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion. J Ethnopharmacol 2009; 121: 412-418
    CrossrefPubMedGoogle Scholar
  • 6 Zhang YY, Wang XY, Wang XR, Xu Z, Liu Z, Ni Q, Chu XP, Qiu MF, Zhao AH, Jia W. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. J Ethnopharmacol 2006; 108: 355-360
    CrossrefPubMedGoogle Scholar
  • 7 Yan B, Wang DY, Xing DM, Ding Y, Wang RF, Lei F, Du LJ. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol Biochem Behav 2004; 78: 319-325
    CrossrefPubMedGoogle Scholar
  • 8 Salim S, Ahmad M, Zafar KS, Ahmad AS, Islam F. Protective effect of Nardostachys jatamansi in rat cerebral ischemia. Pharmacol Biochem Behav 2003; 74: 481-486
    CrossrefPubMedGoogle Scholar
  • 9 Li H, Huang W, Wen YQ, Gong GH, Zhao QB, Yu G. Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C.H.Wright. Fitoterapia 2001; 81: 1147-1156
    PubMedGoogle Scholar
  • 10 Zhen XQ, Yu Q, Fang WY, Zhou XC. Effects of dioscin in protection of myocardial ischemic reperfusion injury in Wistar rats. Chin J Clin Med 2006; 13: 341-343
    PubMedGoogle Scholar
  • 11 Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91
    CrossrefPubMedGoogle Scholar
  • 12 Oshio K, Binder DK, Yang B, Schecter S, Verkman AS, Manley GT. Expression of aquaporin water channels in mouse spinal cord. Neuroscience 2004; 127: 685-693
    CrossrefPubMedGoogle Scholar
  • 13 Yang JH, Li JH, Lu J, Zhang YY, Zhu ZH, Wan HT. Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia. J Ethnopharmacol 2012; 140: 64-72
    CrossrefPubMedGoogle Scholar
  • 14 Thiyagarajan M, Sharma SS. Neuroprotective protective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004; 74: 969-985
    CrossrefPubMedGoogle Scholar
  • 15 Ginsberg MD. Neuroprotection in brain ischemia: an update (part 1 and 2). Neuroscientist 1995; 1: 95
    CrossrefPubMedGoogle Scholar
  • 16 Radi R, Backman JS, Bush KM, Freeman BA. Peroxynitite induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487
    CrossrefPubMedGoogle Scholar
  • 17 Huang ZH, Hang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883-1885
    CrossrefPubMedGoogle Scholar
  • 18 Jung DH, Park HJ, Byun HE, Park YM, Kim TW, Kim BO, Um SH, Pyo S. Diosgenin inhibits macrophage-derived inflammatory mediators through down regulation of CK2, JNK, NF-κB and AP-1 activation. Int Immunopharmacol 2010; 10: 1047-1054
    CrossrefPubMedGoogle Scholar
  • 19 Willmot M, Gibson C, Gray L, Murphy S, Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med 2005; 39: 412-425
    CrossrefPubMedGoogle Scholar
  • 20 Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13-20
    CrossrefPubMedGoogle Scholar
  • 21 Liang ZQ, Li YL, Zhao XL, Han R, Wang XX, Wang Y, Chase TN, Bennett MC, Qin ZH. NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p 53. Brain Res 2007; 1145: 190-203
    CrossrefPubMedGoogle Scholar
  • 22 Choi JS, Kim HY, Cha JH, Lee MY. Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus. Neurosci Lett 2006; 409: 187-191
    CrossrefPubMedGoogle Scholar
  • 23 Roux PP, Blenis J. ERK and p 38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320-344
    CrossrefPubMedGoogle Scholar
  • 24 Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV. Activation of p 38MAPK in microglia after ischemia. J Neurochem 1998; 70: 1764-1767
    PubMedGoogle Scholar
  • 25 Shamloo M, Rytter A, Wieloch T. Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 1999; 93: 81-88
    CrossrefPubMedGoogle Scholar
  • 26 Zhang XX, Liang JR, Liu JL, Zhao Y, Gao J, Sun WJ, Ito Y. Quality control and identification of steroid saponins from Dioscorea zingiberensis C.H. Wright by fingerprint with HPLC-ELSD and HPLC-ESI-Quadrupole/Time-of-fight tandem mass spectrometry. J Pharm Biomed Anal 2014; 91: 46-59
    CrossrefPubMedGoogle Scholar
  • 27 Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A 1999; 96: 12866-12869
    CrossrefPubMedGoogle Scholar
  • 28 Hatashita S, Hoff JT, Salamat SM. Ischemic brain edema and the osmotic gradient between blood and brain. J Cereb Blood Flow Metab 1988; 8: 552-559
    CrossrefPubMedGoogle Scholar